首页> 外国专利> STRAIN OF CULTURED ANIMAL CELLS OF MUS MUSCULUS L EMPLOYED FOR THE PRODUCTION OF A HYBRIDOME

STRAIN OF CULTURED ANIMAL CELLS OF MUS MUSCULUS L EMPLOYED FOR THE PRODUCTION OF A HYBRIDOME

机译:混合体生产所使用的家蝇Mus musculul L的培养动物细胞株

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to u0433u0438u0431u0440u0438 - u0434u043eu043cu043du043eu0439 technology and can be used to obtain a hybrid. the purpose of u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 is a strain of tumor cells - partners with a reduced dependence on u043cu0430u043au0440u043eu0444u0430u0433u0430u043bu044c for u0444u0438u0434u0435u0440u0430, high speed proliferation and u0432u044bu0445u043e house is a hybrid. the strain obtained from the cells of sp 2 / 0 by selection for resistance to methyl u044du0442u0438u0446u0438u044e (ev) in a concentration of 5 mg / ml).the fish in the environment u0434u043cu0435u043c with 10% serum, fetal cows, 1 mm of amino acids, u043fu0438u0440u0443u0432u0430u0442u0430 u043du0430u0442u0440u0438u00a0 1 mm, 2 mm u0433u043bu044eu0442u0430u043cu0438 -, u043cu0435u0440u043au0430u043fu0442u043eu044du0442u0430u043du043eu043bu0430 and 40 iu / ml u0433u0435u043du0442u0430u043c u0438u0446u0438u043du0430. u043fu0442u0430u043cu043c u043eu0442u043bu0438u0447u0430u0435u0442u0441u00a0 source u043fu043eu00a0u0432u043bu0435u043du0438u0435u043c from at least two chromosomal markers, resistance to ev, as well as to 0.5 mg / ml of colchicine and 0074 micrograms / ml u0430u043au0442u0438u043du043eu043cu0438u0446u0438u043du0430 d.u0433u0438u0431u0440u0438u0434u043eu043cu044b obtained during hybridization lymphocytes mice with cells u0437u0430u00a0u0432u043bu00a0u0435u043cu043eu0433u043e strain grown without u0434u043eu0431u0430u0432u043bu0435u043du0438u00a0 monocyte derived macrophages and exit u043fu0440u043eu0434u0443u0446u0435u043du0442u043eu0432 antibodies, double than with the use of the prototype sp 2 / 0 ag 14, the strain is deposited with the no. u0432u0441u043au043a (p) 309u0434. about $
机译:本发明 u043e u0442 u043d u043e u0441 u0438 u0442 u0441 u00a0至 u0433 u0438 u0431 u0440 u0438- u0434 u043e u043c u043d u043d u043e u0439技术可以用于获得混合动力。 u0438 u0437 u043e u0431 u0440 u0435 u0442 u0435 u043d u0438 u00a0的目的是肿瘤细胞株-对 u043c u0430 u043a u043a u0440 u043e u0444的依赖性降低的伙伴 u0430 u0433 u0430 u043b u044c用于 u0444 u0438 u0434 u0435 u0440 u0430,高速扩散和 u0432 u044b u0445 u043e房子是一种混合动力。通过选择对浓度为5 mg / ml的甲基的抗性从sp 2 / 0的细胞中获得的菌株。) u0434 u043c u0435 u043c(含10%血清),胎牛,1毫米氨基酸, u043f u0438 u0440 u0443 u0432 u0430 u0442 u0430 u043d u0430 u0442 u0442 u0440 u0438 u00a0 1毫米,2毫米 u0433 u043b u044e u0442 u0430 u043c u0438-, u043c u0435 u0440 u043a u0430 u043f u0442 u043e u044d u0442 u042 u0430 u043d u043e u043b u0430和40 iu / ml u0433 u0435 u043d u0442 u0430 u043c u0438 u0446 u0438 u043d u0430。 u043f u0442 u0430 u043c u043c u043e u0442 u043b u0438 u0447 u0430 u0435 u0442 u0441 u00a0源 u043f u043e u00a0 u0432 u043b u0435 u043d u0438 u043c来自至少两个染色体标记,对ev具有抗性,以及对0.5 mg / ml秋水仙碱和0074微克/ ml / u0430 u043a u0442 u0438 u043d u043e u043c u0438 u0446 u0438 u043d u0430 d。 u0433 u0438 u0431 u0440 u0438 u0434 u043e u043c u044b在具有细胞 u0437 u0430 u00a0 u0432 u043b u00a0 u0435 u043c u043e u043e的杂交淋巴细胞小鼠中获得在没有 u0434 u043e u0431 u0430 u0432 u043b u0435 u043d u0438 u00a0单核细胞衍生的巨噬细胞的情况下生长的 u043e菌株并退出 u043f u0440 u043e u0434 u0443 u0446 u0435 u043d u0442 u043e u0432抗体,是使用原型sp 2 / 0 ag 14的两倍,菌株的编号为。 u0432 u0441 u043a u043a(p)309 u0434。约$

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号